Record overview
Status and phase
Status: COMPLETED
Phase: PHASE1, PHASE2
Sponsor: City of Hope Medical Center
Condition: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Symptomatic COVID-19 Infection Laboratory-Confirmed
NCT04532372
Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.